DOTmed Home MRI Oncology Ultrasound Molecular Imaging X-Ray Cardiology Health IT Business Affairs
News Home Parts & Service Operating Room CT Women's Health Proton Therapy Endoscopy HTMs Mobile Imaging
SEARCH
Current Location:
>
> This Story


Log in or Register to rate this News Story
Forward Printable StoryPrint Comment
advertisement

 

advertisement

 

MRI Homepage

New VR app may ease MR anxiety Hope to cut down on the need to sedate patients

NYU releases biggest ever MR data set in AI Facebook collaboration With fastMRI, acceleration of imaging by factor of four 'already possible'

Elekta Unity MR-linac gains FDA 510(k) clearance Simultaneously delivers radiation dose and visualization of tumors

The imaging implant conundrum: scanning safely and efficiently The number of people with implanted medical devices is skyrocketing

Making the 'virtual biopsy' a reality with MR spectroscopy New techniques have big potential for MR imaging

Metrasens promotes MR safety data management solution and implant detection study Beyond ferromagnetic detectors

Canon debuts AI for image reconstruction and 1.5T MR at RSNA Advanced Intelligent Clear-IQ Engine and Vantage Orian

Philips debuts versions of its Ingenia Ambition 1.5T MR System Equipped with BlueSeal magnet, can perform helium-free operations

Implants, gadolinium and AI: Changing perceptions in MR From hard questions over contrast retention to softening views on implants

Dr. Michael Recht urges tech, data and AI innovation to rescue imaging at RSNA Insights from the opening session of RSNA 2018

Dr. Daniel Costa, left, and Dr. Ivan
Pedrosa, right, review multiparametric
MRI images

MR and ultrasound 3-D combo prove better at finding early prostate cancer

by John W. Mitchell , Senior Correspondent
It took three years, but a research team at UT Southwestern Medical Center in Dallas has expanded its initial research on 400 patients and has performed its 1,000th MRI-Transrectal Ultrasound (MRI-TRUS) 3-D fusion procedure this month.

The researchers found that the procedure improves the detection of clinically significant prostate cancer.

Story Continues Below Advertisement

Click to visit GE Healthcare Service Shop for ultrasound probe solutions

Get reliable ultrasound probe replacements, faster repair, and service coverage you can count on with GE Healthcare. Service Shop gives customers on-demand access to over 100 OEM new, used, and refurbished probe replacements.



"Our previous study with approximately 400 men has shown that, compared with systematic (conventional, 12-core) biopsy, targeted MRI-TRUS biopsy diagnosed 11 percent more intermediate-to-high risk and 16 percent fewer low-risk tumors," Dr. Daniel Costa, assistant professor of radiology at UT Southwestern Medical Center, told HCB News.

He said that moving forward, the research team — also composed of physicians from the urology and pathology departments at UT — will need to better evaluate the method in other patient populations. This includes determining MRI-TRUS diagnostic performance on the basis of outcome factors, such as disease-free survival and cost-effectiveness.

The researchers have partnered with colleagues in Brazil to conduct two follow-up studies.

According to Costa, their recent expanded study helped confirm several key findings.

"Our work also highlighted its (MRI-TRUS) robustness and consistency," he said. "With these results replicated when using different imaging protocols — such as studies done with and without endo-rectal coil — different image fusion devices, as well as various radiologists and urologists with different levels of expertise."

He added that the use of the MRI-TRUS fusion biopsy has demonstrated that it is a good option for men with high clinical suspicions for prostate cancer, which include elevated and rising PSA blood levels and abnormal digital rectal exams.

Such patients often test negative using conventional TRUS only biopsy. These patients may or may not have prostate cancer and they may or may not have an aggressive form of the disease.

The fused MRI-TRUS image creates a 3-D model, and flags anomalies that could be areas of concern. That helps guide urologists to select biopsy samples to determine whether cancer is present and how severe it may be.

Prostate cancer is the second most common cancer diagnosed in men, after skin cancer. Prostate cancer risk increases with age, with most cases occurring after age 60. According to the National Cancer Institute (NCI), about 180,890 men will be diagnosed this year, and about 14 percent of men will be diagnosed sometime during their lifetime.

"Patients diagnosed at a later stage of disease, or with a more aggressive cancer, have lower rates of survival, making it vital that we quickly identify those who are at the highest risk," said Claus Roehrborn, Chair of the UT Urology Department and a member of the MRI-TRUS study team.

Another team at Virginia Commonwealth University Medical Center is also using a MRI-TRUS method to obtain random tissue samples from 12 cross sections of the prostate to diagnose prostate cancer.

MRI Homepage


You Must Be Logged In To Post A Comment

Advertise
Increase Your
Brand Awareness
Auctions + Private Sales
Get The
Best Price
Buy Equipment/Parts
Find The
Lowest Price
Daily News
Read The
Latest News
Directory
Browse All
DOTmed Users
Ethics on DOTmed
View Our
Ethics Program
Gold Parts Vendor Program
Receive PH
Requests
Gold Service Dealer Program
Receive RFP/PS
Requests
Healthcare Providers
See all
HCP Tools
Jobs/Training
Find/Fill
A Job
Parts Hunter +EasyPay
Get Parts
Quotes
Recently Certified
View Recently
Certified Users
Recently Rated
View Recently
Certified Users
Rental Central
Rent Equipment
For Less
Sell Equipment/Parts
Get The
Most Money
Service Technicians Forum
Find Help
And Advice
Simple RFP
Get Equipment
Quotes
Virtual Trade Show
Find Service
For Equipment
Access and use of this site is subject to the terms and conditions of our LEGAL NOTICE & PRIVACY NOTICE
Property of and Proprietary to DOTmed.com, Inc. Copyright ©2001-2018 DOTmed.com, Inc.
ALL RIGHTS RESERVED